Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
09/2000
09/05/2000US6114137 Preparation of a polypeptide in a culturing vessel; culturing in the vessel a microorganism which utilizes more than one carbohydrate, plating cells on a preferential carbohydrate, incubating the plated cells, detecting propagation
09/05/2000US6114134 Method for assaying biological specimens for substances contained in the components thereof and reagent to be used in this method
09/05/2000US6114132 For determining the binding ability of a ligand to a cysteine-containing wild-type tyrosine phosphatase; medical diagnosis
09/05/2000US6114129 Evaluation of activity of lymphocytes; incubation of sample with antibodies that detect mucin expression, evaluation of mucin expression in control and sample, amplification of mucins are indicative lymphocyte activity
09/05/2000US6114124 Detection of APC proteins
09/05/2000US6114123 Mammalian nucleic acid coding a extracellular transport protein; for the classification, diagnosis, prevention, and treatment of cell proliferative and immune defects
09/05/2000US6114121 Nucleic acid probe molecule of hairpin-shape structure and method for detecting nucleic acids using the same
09/05/2000US6114120 Systematic evolution of ligands by exponential enrichment: tissue selex
09/05/2000US6114119 Transglutaminase and gene encoding same
09/05/2000US6114118 Method of identification of animals resistant or susceptible to disease such as ruminant brucellosis, tuberculosis, paratuberculosis and salmonellosis
09/05/2000US6114117 Homogeneous diagnostic assay method utilizing simultaneous target and signal amplification
09/05/2000US6114116 A nucleic acid sequence for the detection of preferential genotype in plants with a particular phenotype
09/05/2000US6114115 Detecting heterozygosity or a mutation in heterozygous form in a sample; labeling nucleic acids, denaturing nucleic acids, incubating with nucleic acid binding protein, detecting bound heteroduplexes
09/05/2000US6114114 Comparative gene transcript analysis
09/05/2000US6114112 Method of making immunogenic compositions for infectious bursal disease virus
09/05/2000US6114109 Viral (HIV) growth inhibition
09/05/2000US6113914 Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
09/05/2000US6113903 Antidiabetic agents
09/05/2000US6113897 Antibodies and their use
09/05/2000US6113886 Bioluminescent novelty items
09/05/2000US6113816 Kit for conducting an assay to detect a substance using enzymatically-induced decomposition of dioxetanes
09/05/2000US6113762 Microbial electrode and microbial sensor
09/05/2000CA1341094C Diagnosis for malignant hyperthermia
08/2000
08/31/2000WO2000050904A1 Test kit for analysing factor viii-splitting protease
08/31/2000WO2000050902A2 High throughput assay based on the use of a polypeptide binding pair
08/31/2000WO2000050901A1 Protein assay
08/31/2000WO2000050898A1 Method for presuming restenosis following coronary vessel intervention
08/31/2000WO2000050896A1 Compositions and methods for monitoring the modification of engineered binding partners
08/31/2000WO2000050895A1 Isolating a cytoplasmic fraction without impairing the viability of oocytes and embryonic cells
08/31/2000WO2000050892A1 An in vivo and in vitro model for cutaneous photoaging and oxidative damage
08/31/2000WO2000050872A2 A system for cell-based screening
08/31/2000WO2000050871A1 Microstructures for use in biological assays and reactions
08/31/2000WO2000050869A2 Snp detection
08/31/2000WO2000050645A1 Method and kit for early cancer prediction
08/31/2000WO2000050644A2 Methods for purifying dna using immobilized capture probes
08/31/2000WO2000050643A2 Method for detecting radiation exposure
08/31/2000WO2000050642A1 Sequencing by incorporation
08/31/2000WO2000050641A1 T CELL RECEPTOR Vβ-Dβ-Jβ SEQUENCE AND METHODS FOR ITS DETECTION
08/31/2000WO2000050640A1 Methods for preserving dna integrity
08/31/2000WO2000050639A2 Gene sequence variations with utility in determining the treatment of disease
08/31/2000WO2000050638A1 Diagnosis and therapy of premature ovarian failure
08/31/2000WO2000050637A1 Identification of genes having a role in the presentation of diabetic nephropathy
08/31/2000WO2000050635A1 Methods and compositions using binding partners
08/31/2000WO2000050634A1 Sterilization indicator for liquid peracetic acid procedures
08/31/2000WO2000050633A1 Method for cloning signal transduction intermediates
08/31/2000WO2000050632A2 Polymorphic dna fragments and uses thereof
08/31/2000WO2000050631A2 Compositions and methods for monitoring the modification of natural binding partners
08/31/2000WO2000050630A2 Assay for measuring different enzyme activities simultaneously
08/31/2000WO2000050629A2 Diagnostic and screening method for male infertility
08/31/2000WO2000050626A1 Methods for making morpholino-nucleotides, and their use for analysing and marking nucleic acid sequences
08/31/2000WO2000050608A1 Novel polypeptide
08/31/2000WO2000050607A2 Goodpasture antigen binding protein
08/31/2000WO2000050605A1 Avermectin aglycon synthase genes
08/31/2000WO2000050603A1 Attenuated chicken-pox virus oka strain gene 62 and method for identifying virus strain for attenuated live chicken-pox vaccine by using the gene
08/31/2000WO2000050596A2 14273 receptor, a novel g-protein coupled receptor
08/31/2000WO2000050587A1 Genetically filtered shotgun sequencing of complex eukaryotic genomes
08/31/2000WO2000050580A2 Composition, methods and reagents for the synthesis of a soluble form of human phex
08/31/2000WO2000050566A2 Genes encoding insect odorant receptors and uses thereof
08/31/2000WO2000050565A2 Compositions, kits, and methods relating to the human fez1 gene, a novel tumor suppressor gene
08/31/2000WO2000050564A2 Method for extracting dna from dried specimens
08/31/2000WO2000050562A2 Dna encoding snorf25 receptor
08/31/2000WO2000050453A1 A novel inhibitor of programmed cell death
08/31/2000WO2000050446A1 Oligopeptide derivatives for the electrochemical measurement of protease activity
08/31/2000WO2000050436A1 Receptor isogenes: polymorphisms in the tissue necrosis factor receptor
08/31/2000WO2000050399A1 Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy
08/31/2000WO2000050172A1 Manipulation of microparticles in microfluidic systems
08/31/2000WO2000050062A2 Methods and compositions for altering mucus secretion
08/31/2000WO2000049876A1 System and method for evaluating agents which prevent oxidative damage
08/31/2000WO2000043492A8 Method of site specific labeling of proteins and uses therefor
08/31/2000WO2000028079A3 Genetic variation associated with aplastic anemia, and diagnosis and therapy based thereon
08/31/2000WO2000028038A3 Virulence genes and proteins, and their use
08/31/2000WO2000028029A3 Cell surface glycoproteins
08/31/2000WO2000026236A3 Method of modulating cell differentiation or neoplastic transformation by altering cadherin-11 expression or function
08/31/2000WO2000025805A8 Vascular endothelial growth factor-like protein from orf virus nz2 binds and activates mammalian vegf receptor-2
08/31/2000WO2000023465A3 Methods and reagents for isolating biologically active peptides
08/31/2000WO2000022171A3 Systems and methods for sequencing by hybridization
08/31/2000WO2000022170A9 Metabolic selection methods
08/31/2000WO2000022128A9 Protein conjugates containing multimers of green fluorescent protein
08/31/2000WO2000019200A9 Identifying agents that alter mitochondrial permeability transition pores
08/31/2000WO2000018923A9 Slgp protein and nucleic acid molecule and uses therefor
08/31/2000WO2000018910A9 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof
08/31/2000WO2000018803A3 Antibodies to mammalian langerhans cell antigen and their uses
08/31/2000WO2000018795A9 Compositions and methods for wt1 specific immunotherapy
08/31/2000WO2000017103A3 Inventory control
08/31/2000WO2000001375A3 Calcium channel blockers
08/31/2000DE19920704C1 Verwendung eines gegen Harn-Trypsin-Inhibitors gerichteten Antikörpers für die Diagnose des Ausbruchs von AIDS The use of an anti-urinary trypsin inhibitor antibody for the diagnosis of the outbreak of AIDS
08/31/2000DE19904674A1 Verfahren zur Bestimmung der Konzentration von Thrombininhibitoren A method for determining the concentration of thrombin inhibitors
08/31/2000DE19903576A1 Quantitative Bestimmung von Analyten in einem heterogenen System Quantitative determination of analyte in a heterogeneous system
08/31/2000DE19811618C1 Ribozym codierende DNA und ein Oligonucleotidsubstrat enthaltende Zusammensetzung und Verfahren zur Messung von Transkriptionsraten Ribozyme encoding DNA and oligonucleotide substrate containing a composition and method for the measurement of transcription rates
08/31/2000CA2400922A1 Diagnostic and screening method for male infertility
08/31/2000CA2372131A1 Polymorphic dna fragments and uses thereof
08/31/2000CA2371890A1 Methods for making morpholino-nucleotides, and their use for analysing and marking nucleic acid sequences
08/31/2000CA2369002A1 Methods for purifying dna using immobilized capture probes
08/31/2000CA2366951A1 Methods and compositions for altering mucus secretion
08/31/2000CA2365089A1 Identification of genes having a role in the presentation of diabetic nephropathy
08/31/2000CA2365042A1 Compositions and methods for monitoring the modification of natural binding partners
08/31/2000CA2365019A1 Novel polypeptide
08/31/2000CA2365011A1 Genetically filtered shotgun sequencing of complex eukaryotic genomes
08/31/2000CA2364966A1 Genes encoding insect odorant receptors and uses thereof
08/31/2000CA2363827A1 Oligopeptide derivatives for the electrochemical measurement of protease activity